Research ArticleClinical Investigation
Retrospective Analysis of 18F-FDG PET/CT for Staging Asymptomatic Breast Cancer Patients Younger Than 40 Years
Christopher C. Riedl, Elina Slobod, Maxine Jochelson, Monica Morrow, Debra A. Goldman, Mithat Gonen, Wolfgang A. Weber and Gary A. Ulaner
Journal of Nuclear Medicine September 2014, jnumed.114.143297; DOI: https://doi.org/10.2967/jnumed.114.143297
Christopher C. Riedl
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
Elina Slobod
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
Maxine Jochelson
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
2Department of Radiology, Weill Cornell Medical College, New York, New York
Monica Morrow
3Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York; and
Debra A. Goldman
4Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York
Mithat Gonen
4Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York
Wolfgang A. Weber
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
2Department of Radiology, Weill Cornell Medical College, New York, New York
Gary A. Ulaner
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
2Department of Radiology, Weill Cornell Medical College, New York, New York
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 10
October 1, 2024
Retrospective Analysis of 18F-FDG PET/CT for Staging Asymptomatic Breast Cancer Patients Younger Than 40 Years
Christopher C. Riedl, Elina Slobod, Maxine Jochelson, Monica Morrow, Debra A. Goldman, Mithat Gonen, Wolfgang A. Weber, Gary A. Ulaner
Journal of Nuclear Medicine Sep 2014, jnumed.114.143297; DOI: 10.2967/jnumed.114.143297
Retrospective Analysis of 18F-FDG PET/CT for Staging Asymptomatic Breast Cancer Patients Younger Than 40 Years
Christopher C. Riedl, Elina Slobod, Maxine Jochelson, Monica Morrow, Debra A. Goldman, Mithat Gonen, Wolfgang A. Weber, Gary A. Ulaner
Journal of Nuclear Medicine Sep 2014, jnumed.114.143297; DOI: 10.2967/jnumed.114.143297
Jump to section
Related Articles
Cited By...
- Impact of 18F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer: Results from a Prospective Double-Center Trial
- The Current and Future Roles of Precision Oncology in Advanced Breast Cancer
- Overuse of Chest CT in Patients With Stage I and II Breast Cancer: An Opportunity to Increase Guidelines Compliance at an NCCN Member Institution
- Rate of Distant Metastases on 18F-FDG PET/CT at Initial Staging of Breast Cancer: Comparison of Women Younger and Older Than 40 Years
- Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers
- 18F-FDG PET/CT for Staging and Restaging of Breast Cancer
- Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma
- Reply: Breast Cancer Staging: To Which Women Should 18F-FDG PET/CT Be Offered?
- Breast Cancer Staging: To Which Women Should 18F-FDG PET/CT Be Offered?